Paper36722972
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
Schindewolf C and 17 others. J Virol, 2023. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3. Papers, record 36722972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36722972
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptor Proteins, Signal Transducing | Major topic |
| Intracellular Signaling Peptides and Proteins | Major topic |
| SARS-CoV-2 | Major topic |
| Viral Nonstructural Proteins | Major topic |
| COVID-19 | |
| Interferon Type I | |
| Methyltransferases | |
| RNA-Binding Proteins | |
| Animals | |
| Cricetinae |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 AI145400 | NIAID NIH HHS | United States | R21AI145400 | PubMed and NIH | NIH RePORTER |
| R35 GM133633 | NIGMS NIH HHS | United States | R35GM133633 | PubMed and NIH | NIH RePORTER |
| U19 AI171413 | NIAID NIH HHS | United States | U19AI171413 | PubMed and NIH | NIH RePORTER |
| R01 AI153602 | NIAID NIH HHS | United States | R01AI153602 | PubMed and NIH | NIH RePORTER |
| T32 AI007526 | NIAID NIH HHS | United States | T32AI007526 | PubMed and NIH | NIH RePORTER |
| R24 AI120942 | NIAID NIH HHS | United States | R24AI120942 | PubMed and NIH | NIH RePORTER |
| T32 AI060549 | NIAID NIH HHS | United States | T32AI060549 | PubMed | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 36203546 |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35728038 | Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis. | PLoS Pathog | 2022 | https://conductscience.org/library/papers/35728038 | PubMed |
| 2 | 27240734 | Evolution-guided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals. | Elife | 2016 | https://conductscience.org/library/papers/27240734 | PubMed |
| 3 | 32709887 | Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. | Nat Commun | 2020 | https://conductscience.org/library/papers/32709887 | PubMed |
| 4 | 28251928 | Structure of human IFIT1 with capped RNA reveals adaptable mRNA binding and mechanisms for sensing N1 and N2 ribose 2'-O methylations. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28251928 | PubMed |
| 5 | 31991541 | Return of the Coronavirus: 2019-nCoV. | Viruses | 2020 | https://conductscience.org/library/papers/31991541 | PubMed |
| 6 | 32253226 | An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/32253226 | PubMed |
| 7 | 19864603 | Long double-stranded RNA induces an antiviral response independent of IFN regulatory factor 3, IFN-beta promoter stimulator 1, and IFN. | J Immunol | 2009 | https://conductscience.org/library/papers/19864603 | PubMed |
| 8 | 27304209 | Comparative Structural and Functional Analysis of Bunyavirus and Arenavirus Cap-Snatching Endonucleases. | PLoS Pathog | 2016 | https://conductscience.org/library/papers/27304209 | PubMed |
| 9 | 32979938 | Evasion of Type I Interferon by SARS-CoV-2. | Cell Rep | 2020 | https://conductscience.org/library/papers/32979938 | PubMed |
| 10 | 36285486 | Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction. | EMBO Rep | 2022 | https://conductscience.org/library/papers/36285486 | PubMed |
| 11 | 30626973 | FTSJ3 is an RNA 2'-O-methyltransferase recruited by HIV to avoid innate immune sensing. | Nature | 2019 | https://conductscience.org/library/papers/30626973 | PubMed |
| 12 | 32275914 | Type 1 interferons as a potential treatment against COVID-19. | Antiviral Res | 2020 | https://conductscience.org/library/papers/32275914 | PubMed |
| 13 | 26200010 | Interferon-λ: Immune Functions at Barrier Surfaces and Beyond. | Immunity | 2015 | https://conductscience.org/library/papers/26200010 | PubMed |
| 14 | 33476327 | SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33476327 | PubMed |
| 15 | 34578302 | Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase. | Viruses | 2021 | https://conductscience.org/library/papers/34578302 | PubMed |
| 16 | 23317505 | tRNA binding, structure, and localization of the human interferon-induced protein IFIT5. | Mol Cell | 2013 | https://conductscience.org/library/papers/23317505 | PubMed |
| 17 | 33514944 | Engineering SARS-CoV-2 using a reverse genetic system. | Nat Protoc | 2021 | https://conductscience.org/library/papers/33514944 | PubMed |
| 18 | 18571739 | Flavivirus methyltransferase: a novel antiviral target. | Antiviral Res | 2008 | https://conductscience.org/library/papers/18571739 | PubMed |
| 19 | 35352010 | Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals. | Cell Mol Immunol | 2022 | https://conductscience.org/library/papers/35352010 | PubMed |
| 20 | 24098121 | Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/24098121 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42708611 | Antagonism of stress granules is key to SARS-CoV-2 infection and pathogenesis. | J Virol | 2026 | https://conductscience.org/library/papers/42708611 | PubMed |
| 42548544 | Small extracellular vesicles proteome reveals persistent inflammatory and coagulopathic dysregulation in long-COVID. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548544 | PubMed |
| 42367876 | Antagonism of stress granules key for SARS-CoV-2 infection and pathogenesis. | bioRxiv | 2026 | https://conductscience.org/library/papers/42367876 | PubMed |
| 42037394 | Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42037394 | PubMed |
| 41568342 | S‑Adenosylhomocysteine Analogs Selectively Suppress Pan-Coronavirus Replication by Inhibition of nsp14 Methyltransferase. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/41568342 | PubMed |
| 41532757 | Key residues in SARS-CoV-2 NSP3 hypervariable region are necessary to modulate early stress granule activity. | J Virol | 2026 | https://conductscience.org/library/papers/41532757 | PubMed |
| 41394631 | Key residues in SARS-CoV-2 NSP3 hyper variable region are necessary to modulate early stress granule activity. | bioRxiv | 2025 | https://conductscience.org/library/papers/41394631 | PubMed |
| 41331255 | SARS-CoV-2 EndoU-ribonuclease regulates RNA recombination and impacts viral fitness. | Nat Commun | 2025 | https://conductscience.org/library/papers/41331255 | PubMed |
| 41168347 | Poly(A) tail dynamics, non-adenine incorporation and alternative polyadenylation shape the host transcriptome in COVID-19 pathogenesis. | Sci Rep | 2025 | https://conductscience.org/library/papers/41168347 | PubMed |
| 41093992 | The IFIT2-IFIT3 antiviral complex targets short 5' untranslated regions on viral mRNAs for translation inhibition. | Nat Microbiol | 2025 | https://conductscience.org/library/papers/41093992 | PubMed |
| 41080534 | Mechanism by which porcine transmissible gastroenteritis virus disrupts host innate immunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/41080534 | PubMed |
| 41004586 | Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV. | Sci Adv | 2025 | https://conductscience.org/library/papers/41004586 | PubMed |
| 40952259 | Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2. | J Virol | 2025 | https://conductscience.org/library/papers/40952259 | PubMed |
| 40826253 | Immunological orchestration and dysregulation in COVID-19 pneumonia: from viral pathogenesis to precision therapeutics in the post-pandemic era. | Folia Microbiol (Praha) | 2025 | https://conductscience.org/library/papers/40826253 | PubMed |
| 40593736 | Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids. | Nat Commun | 2025 | https://conductscience.org/library/papers/40593736 | PubMed |
| 40492735 | The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2. | J Virol | 2025 | https://conductscience.org/library/papers/40492735 | PubMed |
| 40220753 | Structural insights into the assembly and regulation of 2'-O RNA methylation by SARS-CoV-2 nsp16/nsp10. | Structure | 2025 | https://conductscience.org/library/papers/40220753 | PubMed |
| 40161656 | The furin cleavage site is required for pathogenesis, but not transmission of SARS-CoV-2. | bioRxiv | 2025 | https://conductscience.org/library/papers/40161656 | PubMed |
| 40132472 | A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3a. | EBioMedicine | 2025 | https://conductscience.org/library/papers/40132472 | PubMed |
| 40092096 | Screening of RNA methyltransferase NSP16 inhibitors against SARS-CoV-2 coronavirus and study of related mechanisms. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/40092096 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36722972
GET https://conductscience.org/api/papers/v1/36722972/references?page=2